Association between collapse and serum creatinine and electrolyte concentrations in marathon runners: a 9-year retrospective study by Fitzpatrick, D et al.
Citation:
Fitzpatrick, D and Walter, E and Leckie, T and Richardson, A and Stacey, M and Hunter, A and
Short, S and Hill, N and Woods, D and Grimaldi, R and Galloway, R and Hodgson, L (2020)
Association between collapse and serum creatinine and electrolyte concentrations in marathon
runners: a 9-year retrospective study. European Journal of Emergency Medicine. ISSN 0969-9546
DOI: https://doi.org/10.1097/MEJ.0000000000000739




The aim of the Leeds Beckett Repository is to provide open access to our research, as required by
funder policies and permitted by publishers and copyright law.
The Leeds Beckett repository holds a wide range of publications, each of which has been
checked for copyright and the relevant embargo period has been applied by the Research Services
team.
We operate on a standard take-down policy. If you are the author or publisher of an output
and you would like it removed from the repository, please contact us and we will investigate on a
case-by-case basis.
Each thesis in the repository has been cleared where necessary by the author for third party
copyright. If you would like a thesis to be removed from the repository or believe there is an issue
with copyright, please contact us on openaccess@leedsbeckett.ac.uk and we will investigate on a
case-by-case basis.





Title: Association between collapse and serum creatinine and electrolyte concentrations in 
marathon runners: a nine year retrospective study. 
 
Short title: Association between collapse and serum creatinine and electrolyte 




Daniel FITZPATRICK (corresponding author) 
Affiliation: aUniversity of Brighton,  
bSt Georges University Hospital NHS Foundation Trust,  
cHospital and Exercise Research in Marathon and Endurance Events in Sussex Group 
Postal address: aWelkin Laboratories, Carlisle Road, Eastbourne, BN20 7SN, bBlackshaw 
Road, London, SW17 0QT, cIntensive Care Unit, Worthing Hospital, Lyndhurst Road, 
Worthing, BN11 2DH 
Email address: dfitzpatrick@doctors.org.uk 
 
Edward WALTER 
Affiliation: dRoyal Surrey County Hospital 
Postal address: dIntensive Care Unit, Royal Surrey County Hospital, Egerton Road,Guildford, 
UK 
Email address: ewalter@nhs.net 
 
Todd LECKIE 
Affiliation: e Department of Anaesthetics, Worthing Hospital,  
cHospital and Exercise Research in Marathon and Endurance Events in Sussex Group 
Postal address: e,cLyndhurst Road, Worthing, BN11 2DH 
Email address: t.d.leckie@gmail.com 
 
Alan RICHARDSON 
Affiliation: aCentre of Stress, Ageing and Disease, University of Brighton 
Postal address: Welkin Laboratories, Carlisle Road, Eastbourne, BN20 7SN, 
Email address a.j.richardson@brighton.ac.uk 
 
Mike STACEY 
Affiliation: f Academic Department of Military Medicine, Research and Clinical Innovation, 
Royal Centre for Defence Medicine,  
g Department of Surgery and Cancer, Imperial College London 
Postal address: f Royal Centre for Defence Medicine, Birmingham, B15 2SQ, g Aryton Road, 
Kensington, London, SW7 5NH 
Email address: Mikestacey23@googlemail.com 
 
Alex HUNTER 
Affiliation: e Department of Anaesthetics, Worthing Hospital,  
cHospital and Exercise Research in Marathon and Endurance Events in Sussex Group 
Association between collapse and serum creatinine and electrolyte concentrations in 
marathon runners. 
 
Postal address: e,cLyndhurst Road, Worthing, BN11 2DH 
Email address: alex.hunter@doctors.org.uk 
 
Steve SHORT 
Affiliation: h Department of Biochemistry Western Sussex NHS Foundation Trust  
cHospital and Exercise Research in Marathon and Endurance Events in Sussex Group 
Postal address: e,cLyndhurst Road, Worthing, BN11 2DH 
Email address: alex.hunter@doctors.org.uk 
 
Neil HILL 
Affiliation:i Department of Endocrinology and Diabetes, Imperial College Healthcare NHS 
Trust,  
Postal address: i Charing Cross Hospital, London, W6 8RF 
Email address  neil.hill@nhs.net 
 
David WOODS 
Affiliation: f Academic Department of Military Medicine, Research and Clinical Innovation, 
Royal Centre for Defence Medicine, j Research Institute for Sport, Physical Activity and 
Leisure, Leeds Beckett University 
Postal address: f Royal Centre for Defence Medicine, Birmingham, B15 2SQ, j Leeds, LS6 2QU 
Email address: doctordrwoods@aol.com 
 
Rachael GRIMALDI 
Affiliation: k Brighton and Sussex NHS Trust 
l Brighton Marathon Medical Team 
Postal address: iEastern Road, Brighton, BN2 5BE 
Email address: rachael.grimaldi@gmail.com 
 
Rob GALLOWAY 
Affiliation: k Brighton and Sussex NHS Trust 
l Brighton Marathon Medical Team 
Postal address: iEastern Road, Brighton, BN2 5BE 
Email address: drrobgalloway@gmail.com 
 
Luke HODGSON 
Affiliation: e Department of Anaesthetics, Worthing Hospital,  
cHospital and Exercise Research in Marathon and Endurance Events in Sussex Group 
k Faculty of Health and Medical Sciences, University of Surrey 
Postal address: Postal address: e,cLyndhurst Road, Worthing, BN11 2DH, k Stag Hill, 
Guildford, GU2 7XH 




Creatinine, sodium, potassium, athlete, point-of-care systems 
 
Declaration of Interests 





Funding sources The authors gratefully acknowledge the financial assistance of BASIS in the 
analysis of samples from the 2019 marathon. 
  







Abnormal biochemical measurements have previously been described in runners following 
marathons. The incidence of plasma sodium levels outside the normal range has been 
reported as 31%, and the incidence of raised creatinine at 30%.  
 
Objectives 
This study describes the changes seen in electrolytes and creatinine in collapsed ((2010-
2019 events) and non-collapsed (during the 2019 event) runners during a UK marathon.  
 
Methods 
Point-of-care sodium, potassium, urea and creatinine estimates were obtained from any 
collapsed runner treated by the medical team during the Brighton Marathons, as part of 
their clinical care, and laboratory measurements from control subjects. 
 
Results 
Results from 224 collapsed runners were available. Serum creatinine was greater than the 
normal range in 68.9%. 6% of sodium results were below, and 3% above, the normal range, 
with the lowest 132 mmol/l. 17% of potassium readings were above the normal range; the 
maximum result was 8.4 mmol/l, but 97% were below 6.0 mmol/l. In the control group 
mean creatinine was significantly raised in both the collapse and control groups, with 55.4% 
meeting the criteria for acute kidney injury, but had resolved to baseline after 24 hours. 
Sodium concentration but not the potassium was significantly raised after the race 
compared with baseline, but only 15% were outside the normal range.  
 
Conclusion 
In this study incidence of a raised creatinine was higher than previously reported. However 
the significance of such a rise remains unclear with a similar rise seen in collapsed and non-
collapsed runners, and resolution noted within 24 hours. Abnormal sodium concentrations 
were observed infrequently, and severely abnormal results were not seen, potentially 
reflecting current advice to drink enough fluid to quench thirst. 
  





Collapse at the end of a marathon common(1,2) and is responsible for 59-85% of all medical 
presentations(3) to event medical teams. In one series at a half marathon the incidence of 
severe collapse was 1.53 per 1000 runners. Although the majority of collapses are benign in 
origin, for example related to orthostatic hypotension or exercise-associated collapse (EAC) 
(4), there are a number of potentially life-threatening causes that need to be identified and 
treated promptly. These include cardiac events, exercise-associated hyponatraemia (EAH), 
and hyper or hypothermia. 
 
As part of the diagnostic process in the field, point-of-care (POC) blood testing for a number 
of biomarkers is increasingly employed (4). Common tests include sodium, creatinine, urea 
and troponin (5). POC testing can supplement the initial history and examination to 
delineate the cause of collapse, such as hyponatraemia, for which early aggressive 
treatment may be required.  
 
A number of studies have compared creatinine levels between collapsed and non-collapsed 
endurance runners (6–15). A recent review (16) described an average increase in creatinine 
levels of 25.7 µmol/l after endurance running events, with 30% of marathon runners in one 
study having levels above the upper limit of normal (17). What is less clear is whether these 
increases represent a true renal insult, potentially exacerbated by dehydration or reduced 
renal blood flow, or due to muscle breakdown or other causes (8) and which runners require 
further assessment or follow-up. The comparison of creatinine levels in collapsed and non-
collapsed runners is an approach that could contribute to the understanding of the 
significance of creatinine changes following marathon running. 
Salt and water loss from prolonged exercise need to be replaced carefully. Historically, 
runners were encouraged not to drink during exercise. The recognition that dehydration 
was a problem changed practice, and from 1996, runners were encouraged to drink liberally 
(18). This policy was complicated by hyponatraemia and cerebral oedema, and in a few 
cases this was fatal(19). In 2003, the International Marathon Medical Directors Association 
(IMMDA) adopted more restrictive fluid guidelines of up to 400-800 ml per hour of race. 
Despite implementation of these guidelines, studies in marathon runners have reported an 
incidence of hyponatraemia of 6% - 13% (20,21) and of hypernatraemia of 25% (21)with a 
range of 123–152 mmol/l (21)Current guidelines are to drink according to thirst, suggesting 
that the body regulates its salt and water balance accurately (22). Even with these 
guidelines, the incidence of hyponatraemia is reported as between 8.2% (6) and 12.5%, even 
in asymptomatic volunteers (23). Data on serum potassium concentrations are reported less 
often, but hyperkalaemia has been reported in 16 % after completing a marathon (17,24). 
This study describes the serum sodium, potassium and creatinine changes observed in a 
cohort of runners immediately after a collapse during the Brighton (UK) Marathon, over a 
nine-year period (2010-2019) The Brighton Marathon is an annual event which has run since 
2010. Around 10,000 runners take part each year. A medical facility with sports medicine 
and critical care doctors is provided at the finishing line to provide immediate treatment to 
runners. The study also compares creatinine levels between collapsed and non-collapsed 
runners at the 2019 marathon, providing the first comparative study of creatinine changes 
in collapsed and non-collapsed marathon runners. 









A total of 307 participants were took part in the Brighton Marathon (Brighton, United 
Kingdom) over a number of years. These were split into collapse and control groups. The 
collapse group (n=227) were runners who presented to one of two main medical tents after 
a collapse between 2010 and 2019. The control group (n=80) took part in the 2019 Brighton 
Marathon and were prospectively recruited after ethical approval and written consent were 
obtained. Recruitment was done through email advertisement before the marathon and a 
physical presence at the pre-marathon exhibition where all runners attended to register for 
the race. Runners were eligible to participate as long as they did not have any pre-existing 
medical conditions and self- reported to be in good health at the time of the race. Consent 
was not taken from the collapsed runners, as the investigations were taken and required for 
clinical care, and the data pooled and anonymised at source. 
Collapsed runners had POC, sodium, potassium, urea and creatinine testing performed using 
the Abbott i-STAT device (Abbott Diagnostics, Maidenhead, UK). Blood was taken during 
initial assessment as part of standard medical care and analysed using the i-STAT device 
onsite in the medical tent. Baseline samples were not obtained as this group were recruited 
retrospectively following their collapse. This method has been validated against other 
creatinine measurement methods previously (25–27). The normal reference ranges for this 
method are as follows; Creatinine 55-115 µmol/l, Urea 2.9-9.4mmol/l, Sodium 138-
146mmol/l and potassium 3.5-4.9 mmol/l 
The control group had conventional laboratory-based biochemistry testing performed at 
baseline (within the 48 hours prior to the race) and within 10 minutes of completing the 
race. A proportion of the control group (28.8% n=23) also provided a sample 24 hours 
following the marathon. Participants returned for this on a voluntary basis as a large 
proportion were not able to stay in the locality of the marathon for the 24 hour sample and 
so were lost to the study at this stage. Blood was taken using a Vacutainer system (BD 
Medical, New Jersey, USA) and measurement taken from serum. This was then transported, 
frozen, to the laboratory within two hours of sampling. The normal reference range for 




Data on all creatinine and electrolyte samples before and after the marathon in both groups 
were assessed for normality using the Shapiro-Wilk test. In the control group, the 
dependent (paired) t-test was used to compare baseline creatinine levels with creatinine 
levels at the finish line and at 24 hours following race completion. Given the different 
normal reference ranges for the laboratory creatinine test and POC test, an independent t-
test compared the percentage rise above the upper limit of normal between the control and 
collapsed runners at the 2019 marathon, to control for changes in environmental 
conditions, and between the entire collapsed cohort and 2019 control group. 
Mean values for sodium, potassium and urea were compared using unpaired t test and 
proportions outside of the normal range were also reported. In addition, relative risk (RR) 
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was calculated for the collapse and control groups for creatinine, urea and potassium results 
above the normal range and sodium results below the normal range. 
In the control group, pre- and post-marathon results were compared to establish whether 
the post-race results met the criteria for acute kidney injury (AKI), defined by the KDIGO 
criteria as a 50% rise in creatinine or absolute rise of more than 27 µmol/l in a 48-hour 
period (28). 
All values are mean and standard deviation (SD) unless otherwise stated. Statistical analysis 
was performed using R: A language and environment for statistical computing software, 
2019 (R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was 
chosen as a p value <0.05. 
  






Two hundred and twenty-seven collapsed runners warranted on-site immediate 
biochemistry measurement over the nine marathons between 2010 and 2019 (POC data 
were not collected for the 2016 marathon). The mean number of collapses per year was 
25.3 (SD 8.8) and the majority were male (65.6%). The median age (range) was 39.5 years 
(19–57 years). Collapses per year can be seen as supplementary digital content. Table 1 
shows data for electrolytes in control and collapsed runners. Figure 1 shows distribution of 
results for the different POC tests. 
 
Control 
None of the control group suffered a collapse or reported significant new medical symptoms 
post-race. Table 1 also contains data for control runners before and after the marathon. 
As per table 1, the mean creatinine was significantly elevated between baseline and 
immediately after completing the marathon (p < 0.01).  In those tests, creatinine levels were 
returning to normal after 24 hours; the mean creatinine was not significantly elevated 
between baseline and the 24 hour post-race sample (p = 0.01) (figure 2a). 
The baseline sodium concentration was lower than the race sodium concentration 
immediately after the race in the control group (p=0.001). The baseline potassium 
concentration did not differ from the concentration immediately after the race (p=0.35). 
Baseline urea concentration was significantly lower than the post-marathon urea 
concentration (p<0.001). 
 
Forty-six (55.4%) controls met the KDIGO criteria (28) for AKI immediately following the 
race. After 24 hours, one patient (4.3 %) still met the AKI criteria. Using a chi-squared test, 
there was a statistically significant difference in the proportion of participants with an AKI 
between the two time points (p<0.001). This is shown in Table 2. 
 
Control and collapse 
When comparing the control and collapsed runners, the mean rise above the creatinine 
assay upper limit of normal was not different between the 2019 control group (M = 114.6 
µmol/l, SD 22.9) and the 2019 collapsed runners (M = 106.9 µmol/l, SD 29.3), t(30.18) = 
1.17, p = 0.25, or between the 2019 control group and the entire cohort of collapsed 
runners (M = 119.43 µmol/l, SD 32.34), t(198.17) = 1.42, p = 0.16. Figure 2b shows the 
comparison between creatinine levels immediately after completing the marathon between 
the control group and the collapsed runners. The former analysis between the 2019 control 
and collapse group is included as the environmental and other conditions were identical 
between the groups. 
 
Table 1 shows comparisons between control and collapsed runners for sodium, potassium 
and urea. When comparing sodium concentration between control and collapsed runners, 
there was no statistically significant difference (p=0.98). The same was true for urea 
concentration (p=0.71); however, serum potassium was higher in collapsed runners when 
Association between collapse and serum creatinine and electrolyte concentrations in 
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compared to controls (p<0.0001). Table 3 details RR for creatinine and electrolyte results 




In this large group of marathon runners, we found a large proportion of asymptomatic 
runners to have an AKI after running a marathon, and a similar proportion of these runners 
to  have a raised creatinine concentration compared to collapsed runners. In the majority of 
the asymptomatic runners, creatinine levels had returned to near baseline after 24 hours. 
Additionally, we found similar serum sodium concentrations in these two groups, and a far 
lower incidence of hyponatraemia in collapsed runners than previously reported. 
 
Creatinine results in collapsed and non-collapsed runners 
A raised serum creatinine level after a marathon is well recognised, but to our knowledge, 
this is the largest reported cohort of post-race serum creatinine results in collapsed 
marathon runners. Nearly three quarters of all collapsed runners recorded elevated serum 
creatinine levels, consistent with some previous smaller studies (16, 24), although others 
suggest a much lower incidence, around 30-40% of marathon runners (11,17). However, the 
current study also shows comparisons to non-collapsed runners (controls) completing the 
same marathon course. A similar proportion of non-collapsed runners demonstrated a post-
marathon creatinine level above the normal range, with 55.4 % of these having an AKI, as 
defined by the KDIGO criteria (28), consistent with existing literature (6,7,9,11,13,15,30). 
This makes the clinical interpretation and significance if any of a raised creatinine result in 
the collapsed runner challenging. Consistent with the results in the current study, a previous 
study (49) also reported a rapid return to normal levels, with only 9% showing persistent 
abnormal levels after 24 hours. However, a much smaller number of participants provided 
24 hour samples and so it is not clear whether all of those with an AKI would have normal 
results at that time point. 
 
Whilst the likelihood of collapsed runners having an elevated creatinine was not on average 
different to control runners, when the creatinine was raised, it was on average 11 % higher, 
relative to the normal range, than in non-collapsed runners. This raises the possibility that 
these individuals may be at greater risk of subsequent complications or morbidity. 
 
Potential causes of raised creatinine 
The pathophysiology of a raised creatinine in endurance exercise is likely to be multifactorial 
and has been reviewed by members of this research groups previously(16), However the 
causes may be related to muscle breakdown and true renal dysfunction. Creatinine has 
been shown to increase following exercise, suggesting it may be present as part of normal 
skeletal muscle breakdown following exercise (31). Although levels of creatine kinase in 
rhabdomyolysis may predict development of significant AKI (32), this is not frequently 
observed in endurance events (16). However, in the presence of an acidic environment 
within the renal tubules, high levels of myoglobin precipitate with uromodulin to form casts 
and AKI ensues, though vasoconstriction, direct toxicity of myoglobin and release of 
cytokines all probably contribute (34,35). It is likely that in most endurance runners, the 
physiological response of the kidneys is sufficient to cope with the muscle breakdown 
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products and it is only the presence of multiple risk factors that significant injury, requiring 
medical treatment, can occur(36). 
Subclinical renal injury immediately following a marathon does however also exist with 
levels of cystatin C, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury 
molecule-1 in the urine having been observed to rise immediately after a marathon (11). 
These biomarkers are a more sensitive and are earlier measures of renal filtration than 
creatinine, suggesting that renal filtration rate falls immediately following a marathon. 
Runners are therefore at risk of renal dysfunction (37), in the subsequent few days. True 
renal injury may be due to catecholamine-driven renal hypoperfusion producing a 
transiently reduced glomerular filtration rate (GFR) and a subsequent increase in serum 
creatinine (28,29).  
Contributory factors common to all runners during an event include relative dehydration 
from sweat losses (13), preceding/intra-race illness (such as gastroenteritis) the use of 
NSAIDs (with resulting renal vasoconstriction), diuretics or ACE inhibitors; the combination 
of the latter three significantly increase the risk of AKI (30,31). High ambient temperatures 
can also predispose to heat related illness, a common cause of collapse(3) and risk factor for 
AKI. Increased core temperature itself is associated with increased rates of myoglobinaemia 
and can cause microvascular changes that induce renal dysfunction (42). In the context of 
this extreme physiological disturbance, true renal injury may occur with short-term damage 
and if recurrent, contribute to chronic kidney dysfunction. 
 
Clinical implications 
Overall, there are a number of potential mechanisms for the transient creatinine rise 
observed in apparently healthy marathon runners in this study. However, this study 
demonstrates that these runners are as likely to have a raised creatinine as those who 
collapse. In addition, a proportion of collapsed runners may have further pathological 
causes for a raised creatinine such as heat illness or rhabdomyolysis(3) which may explain 
their greater relative rise. Unlike in exertional heatstroke management, where repeated 
blood tests are performed to ensure resolution of biochemical abnormalities (37), no such 
guidelines for exertional AKI exist. However, the finding that the majority of raised 
creatinine levels return to baseline within 24 hours in asymptomatic runners may be 
reassuring and consistent with previous findings (12, 14, 18). To help guide the need for 
follow-up, clinical signs and symptoms, the likely underlying cause of the creatinine rise, and 
co-existing pathologies and medication use will best determine the need for follow up of 
renal function. AKI following a marathon is, however, on occasion, severe enough to require 
renal replacement therapy (47, 48). With the high incidence of a raised serum creatinine 
after marathon running, it would be prudent to advise runners to avoid or minimise any 
factors, including drugs, which could further increase serum creatinine, or exacerbate 
potential renal dysfunction.  
This study demonstrated that creatinine returns to near normal levels in 24 hours in a 
cohort of non-collapsed runners. Furthermore, creatinine is an imperfect measurement of 
renal function (38, 39). Authors of previous studies have suggested that the standard 
normal ranges are not appropriate for use in an athletic population for this reason (27, 40). 
However, interpreting a much higher result, particularly if a runner is unwell, is more 
difficult. A similar effect has been noted by our group in serum troponin rises, normally 
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employed to detect myocardial ischaemia (7, 41) For this reason, better biomarkers for AKI 
are desirable (49). Biomarkers other than creatinine, such as NGAL, KIM-1 and cystatin are 
more direct measures of renal injury (26, 43) and may have less potential to be increased 
following endurance exercise (16). Further study in this area, including the response to 
running a marathon, and patterns seen in collapsed runners, may allow biomarkers to be 
employed to better risk-stratify runners. This may be significant as it has been postulated 
that repeated low-grade insults may have long-term implications that should be considered 
(13), the use of novel biomarkers may help to identify these changes. 
 
Sodium / Potassium 
In the current study, the incidence of abnormal sodium levels was markedly lower than 
previously reported (7, 8, 11), and severely abnormal results were not seen. None of the 
results were outside the detectable range of the analyser, and very unlikely to have any 
clinical effect. Furthermore, when comparing runners who had experienced a collapse and 
required help from the medical team to asymptomatic volunteers there was no difference in 
their sodium concentration after the marathon. It is not clear why the current study has 
more normal results, but it may reflect a previous changes to hydration strategy advice 
given to marathon runners. 
Initial advice was to drink prescribed amounts of water at regular intervals(51) which may 
have contributed to hyponatraemia secondary to increased total water volume(52). 
However, in 2006 (53) this advice changed to drinking to thirst, in recognition that 
individuals lose water at variable rates and so a prescribed amount will be excessive for 
some and insufficient for others. Despite this change in 2006, a study at the 2010 London 
Marathon showed only 25.3% of runners were using this strategy, although this increased to 
48.7% in 2014(54). The earliest marathon in this study was in 2010 and studies showing a 
higher incidence of hyponatraemia (20,21) were generally published prior to the change in 
recommendations. The decreased incidence demonstrated here may be the result of 
changes in runner behaviours in response to the change in recommendations and 
education. 
Hyponatraemia in runners is thought to be dilutional secondary to increased water 
consumption during running, or to inappropriate vasopressin secretion (55); current 
guidelines to drink only to thirst (22,52) may have reduced the incidence of clinically 
important hyponatraemia. It is generally accepted that the body has good homeostatic 
mechanisms to maintain accurate salt and water balance, and other methods of assessing 
hydration during exercise, for example, calculating fluid loss, or assessing the colour of 
urine, may be over-complicated or less accurate than simply drinking to thirst. A meta-
analysis of data from cyclists taking part in time trials concluded that the best strategy for 
gauging fluid replacement was to rely on thirst (56). There has also been much debate 
recently on the merits or otherwise of manufactured sports drinks. Recent work (57) 
suggested that water is as effective, safe and cheaper than commercially available products. 
The majority of runners in the Brighton Marathon drink water as dictated by thirst (Walter 
EJ, 2012, unpublished data), so this current study would support advice to drink to thirst, 
and that water does not cause significant electrolyte derangement. 
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Potassium has less often been implicated in collapse in marathon runners, but 
hyperkalaemia can result in arrythmias and cardiac arrest. Previous studies have shown a 
prevalence of 16 % (3, 49); these results are consistent with findings in the current study, 
which show an incidence of hyperkalaemia above the normal range of 17.4 %, and 
hypokalaemia of 2.2 %. Although collapsed runners did have a higher average potassium 
concentration after the marathon, the absolute difference was small and unlikely to be of 
clinical importance. Of note, the proportion of runners with a clinically importantly raised 
potassium (defined as greater than 6.0 mmol/l (58)) in the current study was low at 3.1 %. 
This suggests that whilst most collapsed runners will not need to be treated for 
hyperkalaemia, a small number may require urgent treatment to prevent cardiac 
complications. A clinically important hyperkalaemia was therefore uncommon in this study, 
and severe hyperkalaemia was very rarely seen. These results should be taken with caution, 
however, as haemolysis cannot be assessed with the i-STAT device, and potassium levels 
may therefore be overestimated. 
Limitations 
This study has a number of limitations. The main analysis was a retrospective analysis of 
historical POC results in collapsed runners, with the data primarily collected to aid clinical 
decision-making. Clinical details of collapsed runners were unavailable to the authors and as 
a result the cause of collapse, and medical and medication history are unclear. Availability of 
these would allow more detailed analysis including testing the hypothesis that cause of 
collapse may contribute to the heterogeneity of collapsed runner’s creatinine levels. For the 
collapsed runners, baseline and follow-up creatinine results were absent. These would be 
useful for an understanding of peri-event renal function. Of note though, only 6.3% of 
control runners had a pre-race creatinine outside the normal range, meaning prevalence of 
pre-existing renal disease was likely to be low. However, this could also represent increased 
muscle bulk in trained athletes. The incidence of changes in urea concentration is low (18 
%), suggesting that pre-race AKI is rare. 
 
In addition to this, a far smaller number of participants in the control group provided a 24 
hour sample than dad immediately following the race. Although creatinine levels returned 
to near normal at this time point, this result should be interpreted with caution as we were 
unable to confirm that all abnormal results improved in this way. 
 
  




In a nine-year review of a marathon event we have demonstrated a consistent increase in 
serum creatinine levels immediately following completion of the race. Whilst the prevalence 
of a post-marathon creatinine rise was similar between collapsed and non-collapsed 
runners, this study demonstrated that the degree of rise is greater in those who experience 
a collapse. Additionally, levels return to normal after 24 hours in non-collapsed runners. This 
means it may be difficult to use post-race creatinine levels to determine those at risk of 
actual renal injury. Further research is required to validate novel biomarkers of renal injury 
and to establish the long-term significance of a raised creatinine after running a marathon 
and who, if any, may be at risk of a longer-term renal injury. 
In addition, we have demonstrated a lower prevalence of hyponatraemia and 
hypernatraemia than had been previously reported. This may be the result of revised 
hydration guidance for runners preventing dilutional hyponatraemia in particular. In 
addition, sodium concentrations were similar in collapsed and asymptomatic runners. This 
may help clinicians providing medical care at marathon events plan for expected cases. 
  




The authors are grateful to the subjects for enrolling in the study. 
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Figure 1: Box and Whisker plots for POC testing in collapsed runners. A-Sodium, B- 
Potassium, C- Creatinine, D- Urea 
 
Figure 2: A- Baseline, finish line and 24-hour post-marathon serum creatinine for control 
runners. Thick black line represents mean for each group. B- Post-race creatinine as a 
percentage of the upper normal range 
 
Table 1- Data for creatinine, sodium, potassium and urea concentrations. *Different normal 
ranges for creatinine measurement in control and collapsed participants  
 
Table 2- Creatinine results and AKI status of control runners immediately before, 
immediately after, and 24h after completing marathon. 
 
Table 3- Risk Ratios (RR) for creatinine and electrolyte disturbance comparing control and 
collapse groups immediately after completing marathon. 
